Israeli pharmaceuticals company,the world’s largest generic drugmaker, says the acquisition will give patients more access to affordable medicinesIsrael’s Teva is purchasing Dublin-based Allergan PLC’s generic pharmaceuticals trade for $40.5bn (£26.1bn), or in what analysts are calling the largest ever acquisition by an Israeli company.
Statements from both companies say the deal will see Allergan receive $33.75bn in cash and shares of Teva valued on Monday at $6.75bn. In light of the acquisition,Teva said it was withdrawing its $40bn-plus takeover offer for pharmaceuticals company Mylan.
Continue reading...
Source: theguardian.com